In this Section |
208796 Quality of social networks and its impact on drug treatment entry and attendanceTuesday, November 10, 2009
Objectives: Previous studies have shown that social networks are associated with entry into drug treatment among drug users. Few studies have described the composition of those networks. Our objective was to determine if composition of social support networks was associated with treatment and/or detox entry, and length of stay in treatment. Methods: Participants (N=1040) were recruited from 38 New York City high risk neighborhoods using street-intercept sampling. Multivariable models were used to examine the associations between social network variables and drug treatment participation and length of stay in treatment in the last six months. Results: Participants were predominantly male (66.9%), Black (45%) and Hispanic (43%). 44% had been in treatment in the last six months. In fully adjusted models, participants who had one or more network members whom they could ask information about social services had a higher chance of being in treatment than those who did not (OR=2.4;95%CI 1.7-3.4; p<0.0001). Participants who had one or more network members whom they could talk to about personal matters had a lower chance of being in detox than those who didn't (OR=0.6;95%CI 0.4-1.0; p=0.0327). Participants who could stay at a network members' place that they didn't use drugs with spent more days in treatment than those who could stay with people that they used drugs with (beta=22.8;p=0.0075). Conclusion: These data suggest that incorporating social support networks in social service programs including drug treatment may promote treatment entry and length of stay, with the exception of detox where additional research is warranted.
Learning Objectives: Keywords: Treatment Adherence, Substance Abuse Treatment
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: Masters in Global Public Health I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Prevention and other critical issues of importance
See more of: Alcohol, Tobacco, and Other Drugs |